SCOPUS 정보 검색 플랫폼

Volumn 7, Issue 12, 2001, Pages 4008-4012

Her-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation

(9) Kim, Young S a Sahin, Aysegul A a Konoplev, Sergej N a Montemurro, Filippo a Rondón, Gabriela a Champlin, Richard E a Ueno, Naoto T a Hoy, Emma a Smith, Terry L a

a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; ETOPOSIDE; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; THIOTEPA;

ARTICLE; AUTOTRANSPLANTATION; BREAST CANCER; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENES, ERBB-2; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; PROGNOSIS; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0035670905 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (33)

References (28)

1
- 37049183697
- Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
- 1
- (1987) Science (Wash. DC) , vol.235 , pp. 177-182
- Slamon, D.J.¹ Clark, G.M.² Wong, S.G.³ Levin, W.J.⁴ Ullrich, A.⁵ McGuire, W.L.⁶

2
- 0024337144
- Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
- 1
- (1989) Science (Wash. DC) , vol.244 , pp. 707-712
- Slamon, D.J.¹ Godolphin, W.² Jones, L.A.³ Holt, J.A.⁴ Wong, S.G.⁵ Keith, D.E.⁶ Levin, W.J.⁷ Stuart, S.G.⁸ Udove, J.⁹ Ullrich, A.¹⁰ Press, M.F.¹¹

3
- 0029662337
- c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases
- 1
- (1996) J. Clin. Oncol. , vol.14 , pp. 2702-2708
- Carlomagno, C.¹ Perrone, F.² Gallo, C.³ De Laurentiis, M.⁴ Lauria, R.⁵ Morabito, A.⁶ Pettinato, G.⁷ Panico, L.⁸ D’Antonio, A.⁹ Bianco, A.R.¹⁰ De Placido, S.¹¹

4
- 0030860567
- Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer
- 1
- (1997) Clin. Cancer Res. , vol.3 , pp. 1643-1651
- Newby, J.C.¹ Johnston, S.R.² Smith, I.E.³ Dowsett, M.⁴

5
- 0030200381
- Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: A case-control study
- 1
- (1996) Int. J. Radiat. Oncol. Biol. Phys. , vol.35 , pp. 751-757
- Haffty, B.G.¹ Brown, F.² Carter, D.³ Flynn, S.⁴

6
- 0027517374
- Clinical significance of HER-2/neu oncogene amplification in primary breast cancer
- The South Australian Breast Cancer Study Group
- 1
- (1993) J. Clin. Oncol. , vol.11 , pp. 1936-1942
- Seshadri, R.¹ Firgaira, F.A.² Horsfall, D.J.³ McCaul, K.⁴ Setlur, V.⁵ Kitchen, P.⁶

7
- 0028301750
- Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy
- 1
- (1994) Cancer (Phila.) , vol.73 , pp. 2359-2365
- Tetu, B.¹ Brisson, J.²

8
- 0027083049
- Expression of HER-2/neu oncoprotein in human breast cancer: A comparison of immunohistochemical and western blot techniques
- 1
- (1992) Anticancer Res. , vol.12 , pp. 1965-1971
- Molina, R.¹ Ciocca, D.R.² Tandon, A.K.³ Allred, D.C.⁴ Clark, G.M.⁵ Chamness, G.C.⁶ Gullick, W.J.⁷ McGuire, W.L.⁸

9
- 0033889662
- Oncogenes and male breast carcinoma: C-erbB-2 and p53 coexpression predicts a poor survival
- 1
- (2000) J. Clin. Oncol. , vol.18 , pp. 2948-2956
- Pich, A.¹ Margaria, E.² Chiusa, L.³

10
- 0028354305
- c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer
- 1
- (1994) N. Engl. J. Med. , vol.330 , pp. 1260-1266
- Muss, H.B.¹ Thor, A.D.² Berry, D.A.³ Kute, T.⁴ Liu, E.T.⁵ Koerner, F.⁶ Cirrincione, C.T.⁷ Budman, D.R.⁸ Wood, W.C.⁹ Barcos, M.¹⁰ Henderson, I.C.¹¹

11
- 0030223058
- Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (> 10 Involved Lymph Nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapy
- 1
- (1996) Clin. Cancer Res. , vol.2 , pp. 1509-1513
- Bitran, J.D.¹ Samuels, B.² Trujillo, Y.³ Klein, L.⁴ Schroeder, L.⁵ Martinec, J.⁶

12
- 0032780677
- Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support
- 1
- (1999) Bone Marrow Transplant. , vol.24 , pp. 377-384
- Bewick, M.¹ Chadderton, T.² Conlon, M.³ Lafrenie, R.⁴ Morris, D.⁵ Stewart, D.⁶ Gluck, S.⁷

13
- 17144433212
- Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation
- 1
- (2000) J. Clin. Oncol. , vol.18 , pp. 2070-2080
- Nieto, Y.¹ Cagnoni, P.J.² Nawaz, S.³ Shpall, E.J.⁴ Yerushalmi, R.⁵ Cook, B.⁶ Russell, P.⁷ McDermit, J.⁸ Murphy, J.⁹ Bearman, S.I.¹⁰ Jones, R.B.¹¹

14
- 0034986515
- HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support
- 1
- (2001) Bone Marrow Transplant. , vol.27 , pp. 847-853
- Bewick, M.¹ Conlon, M.² Gerard, S.³ Lee, H.⁴ Parissenti, A.M.⁵ Zhang, L.⁶ Gluck, S.⁷ Lafrenie, R.M.⁸

15
- 26544477309
- Selection of candidates for high dose chemotherapy (HDCT) for metastatic breast cancer (MBC): Importance of the Swenerton score and implications of the "Conversion Rate
- submitted to J. Clin. Oncol
- 1
- (2000) Proc. Am. Soc. Clin. Oncol. , pp. 123A
- Montemurro, F.¹ Rondón, G.² Ueno, N.T.³ Munsell, M.⁴ Smith, T.L.⁵ Mehra, R.⁶ Gajewski, J.L.⁷ Rahman, Z.U.⁸ Buzdar, A.U.⁹ Hortobagyi, G.N.¹⁰ Champlin, R.E.¹¹

16
- 0018773378
- Prognostic factors in metastatic breast cancer treated with combination chemotherapy
- 1
- (1979) Cancer Res. , vol.39 , pp. 1552-1562
- Swenerton, K.D.¹ Legha, S.S.² Smith, T.³ Hortobagyi, G.N.⁴ Gehan, E.A.⁵ Yap, H.Y.⁶ Gutterman, J.U.⁷ Blumenschein, G.R.⁸

17
- 33845382806
- Nonparametric estimation from incomplete observations
- 1
- (1958) J. Am. Stat. Assoc. , vol.53 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

18
- 0000336139
- Regression models and life tables
- 1
- (1972) J. of the Royal Statistical Society (B) , vol.34 , pp. 187-220
- Cox, D.R.¹

19
- 0030947407
- HER2 overexpression and paclitaxel sensitivity in breast cancer: Therapeutic implications
- 1
- (1997) Oncology (Huntingt) , vol.11 , pp. 43-48
- Baselga, J.¹ Seidman, A.D.² Rosen, P.P.³ Norton, L.⁴

20
- 0032538050
- erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer
- 1
- (1998) J. Natl. Cancer Inst. (Bethesda) , vol.90 , pp. 1346-1360
- Thor, A.D.¹ Berry, D.A.² Budman, D.R.³ Muss, H.B.⁴ Kute, T.⁵ Henderson, I.C.⁶ Barcos, M.⁷ Cirrincione, C.⁸ Edgerton, S.⁹ Allred, C.¹⁰ Norton, L.¹¹ Liu, E.T.¹²

21
- 0032538040
- erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer
- 1
- (1998) J. Natl. Cancer Inst. (Bethesda) , vol.90 , pp. 1361-1370
- Paik, S.¹ Bryant, J.² Park, C.³ Fisher, B.⁴ Tan-Chiu, E.⁵ Hyams, D.⁶ Fisher, E.R.⁷ Lippman, M.E.⁸ Wickerham, D.L.⁹ Wolmark, N.¹⁰

22
- 0034515613
- HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma
- 1
- (2000) Am. J. Clin. Pathol. , vol.113 , pp. 852-859
- Hoang, M.P.¹ Sahin, A.A.² Ordonez, N.G.³ Sneige, N.⁴

23
- 0028884831
- Bidirectional interactions between the estrogen receptor and the cerbB-2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells
- 1
- (1995) Int. J. Cancer , vol.63 , pp. 560-567
- Grunt, T.W.¹ Saceda, M.² Martin, M.B.³ Lupu, R.⁴ Dittrich, E.⁵ Krupitza, G.⁶ Harant, H.⁷ Huber, H.⁸ Dittrich, C.⁹

24
- 0033392899
- Stem cell transplantation for metastatic breast cancer: Analysis of tumor contamination
- 1
- (1999) Med. Oncol. , vol.16 , pp. 279-288
- Stadtmauer, E.A.¹ Tsai, D.E.² Sickles, C.J.³ Mick, R.⁴ Luger, S.M.⁵ Porter, D.L.⁶ Mangan, P.A.⁷ Schuchter, L.M.⁸ Schuster, S.J.⁹ Loh, E.Y.¹⁰ Magee, D.A.¹¹ Sachs, R.A.¹² Wall, M.E.¹³ Moore, J.¹⁴ Buzby, G.P.¹⁵ Zaleta, E.¹⁶ Kamoun, M.¹⁷ Silberstein, L.E.¹⁸

25
- 0034567765
- Status of high-dose chemotherapy for breast cancer: A review
- 1
- (2000) Biol. Blood Marrow Transplant. , vol.6 , pp. 476-495
- Nieto, Y.¹ Champlin, R.E.² Wingard, J.R.³ Vredenburgh, J.F.⁴ Elias, A.D.⁵ Richardson, P.⁶ Glaspy, J.⁷ Jones, R.B.⁸ Stiff, P.J.⁹ Bearman, S.I.¹⁰ Cagnoni, P.J.¹¹ McSweeney, P.A.¹² LeMaistre, C.F.¹³ Pecora, A.L.¹⁴ Shpall, E.F.¹⁵

26
- 0031903646
- Phase II study of receptor-enhanced chemo-sensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment
- 1
- (1998) J. Clin. Oncol. , vol.16 , pp. 2659-2671
- Pegram, M.D.¹ Lipton, A.² Hayes, D.F.³ Weber, B.L.⁴ Baselga, J.M.⁵ Tripathy, D.⁶ Baly, D.⁷ Baughman, S.A.⁸ Twaddell, T.⁹ Glaspy, J.A.¹⁰ Slamon, D.J.¹¹

27
- 0032825577
- Combination therapy with trastuzumab (Herceptin) and cisplatin for chemoresistant metastatic breast cancer: Evidence for receptor-enhanced chemosensitivity
- 1
- (1999) Semin. Oncol. , vol.26 , pp. 89-95
- Pegram, M.D.¹ Slamon, D.J.²

28
- 0033559619
- Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene
- 1
- (1999) Cancer Res. , vol.59 , pp. 1347-1355
- Pietras, R.J.¹ Poen, J.C.² Gallardo, D.³ Wongvipat, P.N.⁴ Lee, H.J.⁵ Slamon, D.J.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.